Name | Guanosine 3’,5’-Cyclic Monophosphate Sodium Salt |
---|---|
Synonyms |
Guanosine 3',5'-Cyclic Monophosphate Sodium Salt
EINECS 255-056-0 Sodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide 6H-Purin-6-one, 2-amino-3,9-dihydro-9-[(4aR,6R,7R,7aS)-tetrahydro-2,7-dihydroxy-2-oxido-4H-furo[3,2-d]-1,3,2-dioxaphosphorin-6-yl]-, sodium salt (1:1) MFCD00038424 |
Description | Cyclic GMP sodium (cGMP) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug treatment or proliferative signals, it is in response to atrial natriuretic peptide (ANP) or nitric oxide (NO). Cyclic GMP sodium interacts with cation channels to regulate ion transport or activate the cyclic GMP-dependent protein kinase to result in protein phosphorylation[1][2]. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
Molecular Formula | C10H11N5NaO7P |
---|---|
Molecular Weight | 367.187 |
Exact Mass | 367.029388 |
PSA | 187.45000 |
Storage condition | −20°C |
Water Solubility | H2O: 50 mg/mL |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 29349990 |